Skip to main content
STADA Arzneimittel AG logo

STADA Arzneimittel AG — Investor Relations & Filings

Ticker · SAZ ISIN · DE0007251803 LEI · 529900FMTTLMH0P0DL10 HM Manufacturing
Open in API
Filings indexed 916 across all filing types
Latest filing 2012-05-11 Interim / Quarterly Rep…
Country DE Germany
Listing HM SAZ

About STADA Arzneimittel AG

https://www.stada.com/

STADA Arzneimittel AG is a pharmaceutical company that operates on a three-pillar strategy consisting of generics, consumer healthcare products, and specialty pharmaceuticals. The company is a leading manufacturer of affordable generic medicines, which have been a core part of its business since its founding. In the consumer healthcare segment, STADA markets a wide portfolio of over-the-counter (OTC) products and well-known brands. The specialty pharmaceuticals division focuses on developing and marketing value-added medicines, including an expanding portfolio of biosimilars for therapeutic areas such as oncology, immunology, and bone health.

Recent filings

Filing Released Lang Actions
Q1 Report 2012
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Report on the First Three Months of 2012' and contains detailed financial tables (Group sales, EBITDA, EBIT, Net income) comparing Q1 2012 to Q1 2011, along with a comprehensive 'Management Report' section analyzing business performance, regional sales, and earnings. It is a substantive financial report for a period shorter than a full fiscal year, not an announcement or certification, thus fitting the definition of an Interim/Quarterly Report. Q1 2012
2012-05-11 English
STADA: Excellent start in Q1/2012 - Increase in all adjusted key earnings figures - Reported key earnings figures burdened by planned one-time special effects - Positive outlook until 2014 confirmed
Earnings Release Classification · 100% confidence The document text explicitly states, "Today, on May 10, 2012, STADA Arzneimittel AG published the financial results for the first quarter of 2012." It contains detailed financial metrics (Sales, Net income, EBITDA, EPS) for the period 1-3/2012, compares them to the prior year (1-3/2011), and discusses segment performance (Generics, Branded Products) and outlook. This content structure—detailed financial performance for a period shorter than a year—is characteristic of an Interim/Quarterly Report. It is comprehensive, not just a brief highlights release (ER), and it is not the full annual report (10-K). Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q1 2012
2012-05-10 English
Datum:08.05.2012
Annual Report Classification · 100% confidence The document is titled 'STADA-Geschäftsbericht 2011' (Annual Report 2011) and contains comprehensive financial statements, key performance indicators (KPIs), a management report (Bericht des Vorstands), and a supervisory board report (Bericht des Aufsichtsrats) for the fiscal year 2011. It is a full-length annual report, not an announcement or a summary. FY 2011
2012-05-08 German
STADA Arzneimittel Aktiengesellschaft: Korrektur: Bekanntmachung der Einberufung zur Hauptversammlung am 30.05.2012 in Frankfurt am Main mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information Classification · 98% confidence The document is titled 'Korrektur: Bekanntmachung der Einberufung zur Hauptversammlung am 30.05.2012' (Correction: Announcement of the Convocation to the Annual General Meeting on 30.05.2012). It explicitly mentions the 'Hauptversammlung' (General Meeting) and is a correction notice related to the announcement of this meeting. This directly relates to the Annual General Meeting (AGM). Although it is a correction notice, the core subject matter is the AGM convocation, making 'AGM-R' the most appropriate classification over a general 'RNS' or 'LTR'. The document length is short (1152 chars), but it is a specific announcement about the AGM, not just a general report publication announcement.
2012-04-24 German
STADA Arzneimittel Aktiengesellschaft: Bekanntmachung der Einberufung zur Hauptversammlung am 30.05.2012 in Frankfurt am Main mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information Classification · 100% confidence The document is explicitly titled 'Einladung zur ordentlichen Hauptversammlung 2012' (Invitation to the Annual General Meeting 2012) and details the date, location, and agenda for the meeting scheduled for May 30, 2012. The agenda includes standard AGM items like presenting the annual financial statements, approving the use of profits (dividend proposal), and discharging board members. This content directly corresponds to the materials prepared for or announced regarding the Annual General Meeting. Therefore, the classification is AGM-R (AGM Information).
2012-04-20 German
Annual Report 2011
Annual Report Classification · 100% confidence The document is explicitly titled 'STADA Annual Report 2011' and contains comprehensive sections including a letter to shareholders, management report, consolidated financial statements, notes to the financial statements, and an auditor's report. It covers the full fiscal year 2011 and provides detailed financial performance data, making it a standard Annual Report. FY 2011
2012-03-30 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.